2018 and Beyond: South Korea Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in South Korea witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in South Korea and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on South Korea healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the South Korea healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of South Korea pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in South Korea and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on South Korea healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the South Korea healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of South Korea pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 South Korea Pharmaceutical and Healthcare Industry Snapshot
2.2 South Korea Pharmaceuticals Market Overview
3 SOUTH KOREA PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in South Korea
3.2 Drivers and Restraints
3.2.1 Market Drivers in South Korea Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in South Korea Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 SOUTH KOREA PHARMACEUTICAL MARKET OUTLOOK
4.1 South Korea Pharmaceutical Sales, $ Million, 2015- 2025
4.2 South Korea Pharmaceutical Exports, $ million, 2015- 2025
4.3 South Korea Pharmaceutical Imports, $ Million, 2015- 2025
4.4 South Korea (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 South Korea (% contribution) to Global Pharmaceutical Market size, 2017
4.6 South Korea Prescription Drug Sales, $ Million, 2015- 2025
4.7 South Korea Generic Drug Sales, $ Million, 2015- 2025
5 SOUTH KOREA HEALTHCARE MARKET OUTLOOK
5.1 South Korea Healthcare Expenditure Outlook, 2015- 2025
5.2 South Korea Healthcare Expenditure (% of GDP), 2015- 2025
5.3 South Korea Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 South Korea Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in South Korea, 2015- 2025
6 SOUTH KOREA HEALTHCARE MARKET STATISTICS
6.1 South Korea Mortality by Disease Category, 2017
6.2 Number of Hospitals in South Korea, 2007- 2017
6.3 Number of Hospital Beds in South Korea, 2007- 2017
6.4 Physicians Count in South Korea, 2007- 2017
6.5 Pharmacists Count in South Korea, 2007- 2017
7 SOUTH KOREA CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in South Korea, 2017
7.2 Ongoing Clinical Trials by Disease Category in South Korea, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 SOUTH KOREA DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 South Korea Population Forecast by Age Group, 2005- 2025
8.2 South Korea Population Forecast by Location, 2005- 2025
8.3 South Korea GDP Forecast, 2005- 2025
8.4 South Korea GDP Per Capita Forecast, 2005- 2025
8.5 South Korea Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN SOUTH KOREA PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 South Korea Pharmaceutical and Healthcare Industry Snapshot
2.2 South Korea Pharmaceuticals Market Overview
3 SOUTH KOREA PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in South Korea
3.2 Drivers and Restraints
3.2.1 Market Drivers in South Korea Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in South Korea Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 SOUTH KOREA PHARMACEUTICAL MARKET OUTLOOK
4.1 South Korea Pharmaceutical Sales, $ Million, 2015- 2025
4.2 South Korea Pharmaceutical Exports, $ million, 2015- 2025
4.3 South Korea Pharmaceutical Imports, $ Million, 2015- 2025
4.4 South Korea (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 South Korea (% contribution) to Global Pharmaceutical Market size, 2017
4.6 South Korea Prescription Drug Sales, $ Million, 2015- 2025
4.7 South Korea Generic Drug Sales, $ Million, 2015- 2025
5 SOUTH KOREA HEALTHCARE MARKET OUTLOOK
5.1 South Korea Healthcare Expenditure Outlook, 2015- 2025
5.2 South Korea Healthcare Expenditure (% of GDP), 2015- 2025
5.3 South Korea Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 South Korea Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in South Korea, 2015- 2025
6 SOUTH KOREA HEALTHCARE MARKET STATISTICS
6.1 South Korea Mortality by Disease Category, 2017
6.2 Number of Hospitals in South Korea, 2007- 2017
6.3 Number of Hospital Beds in South Korea, 2007- 2017
6.4 Physicians Count in South Korea, 2007- 2017
6.5 Pharmacists Count in South Korea, 2007- 2017
7 SOUTH KOREA CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in South Korea, 2017
7.2 Ongoing Clinical Trials by Disease Category in South Korea, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 SOUTH KOREA DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 South Korea Population Forecast by Age Group, 2005- 2025
8.2 South Korea Population Forecast by Location, 2005- 2025
8.3 South Korea GDP Forecast, 2005- 2025
8.4 South Korea GDP Per Capita Forecast, 2005- 2025
8.5 South Korea Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN SOUTH KOREA PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
